流动负债 更改
AbbVie USD 41.64B 458M 2026-06
Align Technology USD 1.91B 2.74M 2026-06
Bayer EUR 32.27B 1.19B 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Charles River Laboratories USD 1.13B 41.04M 2026-06
Coherus Biosciences USD 75.51M 56.82M 2026-06
Dentsply International USD 1.18B 22M 2026-06
Eli Lilly USD 47.74B 11.11B 2026-06
Henry Schein USD 3.49B 191M 2026-06
Idexx Laboratories USD 1.29B 12.19M 2026-06
Illumina USD 1.58B 12M 2026-06
IQVIA Holdings USD 8.82B 486M 2026-06
J&J USD 54.9B 2.82B 2026-06
Laboratory Of America USD 2.12B 516.4M 2026-06
Merck USD 27.73B 786M 2026-06
Neogen USD 158.2M 7.6M 2026-03
Pacira USD 122.01M 13.22M 2026-06
Perrigo USD 1.05B 57.2M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Phibro Animal Health USD 281.87M 500K 2026-03
Quest Diagnostics USD 1.79B 389M 2026-06
Sanofi EUR 31.93B 1.92B 2026-06
Sanofi EUR 30.01B 1.66B 2026-03
Zoetis USD 2.06B 8M 2026-06